Atombeat Inc. is an AI and computational technology company that accelerates drug discovery programs from concept to preclinical candidate (PCC). Our mission is to make advanced computational drug discovery accessible to all. We provide physics- and AI-based software solutions and services to biotech and pharmaceutical partners across diverse therapeutic modalities, enabling faster and smarter R&D. 

Our proprietary discovery platform RiDYMO is built to tackle hard-to-drug targets by integrating molecular design, high-accuracy computational modeling, and closed-loop experimental feedback. We specialize in making reliable, scalable impact on hit discovery and lead optimization, and combine deep scientific expertise with powerful technology to help customers bring transformative therapies closer to patients.

Atombeat Inc.

Org chart

Teams

Offices